Understanding Your MADD/GA2 Diagnosis

Receiving a diagnosis of Multiple acyl-CoA dehydrogenase deficiency (MADD) is often a moment of profound contradiction. For some, it is the end of a long and exhausting “diagnostic odyssey”—a period of months or even years spent searching for an explanation for unexplained symptoms ^[1][2]. For others, particularly those whose journey began with a newborn screening result, it is a sudden, jarring entry into the world of rare disease ^[3].

Because MADD is an ultra-rare disorder—estimated to occur in approximately 1 in 200,000 births, though rates vary significantly by region—it is highly likely that your local doctors or even emergency room staff have never encountered a case before ^[4][5]. It is normal to feel overwhelmed, isolated, or even skeptical of a name you have never heard. This page is designed to help you ground yourself in the basic facts of the condition and clear up common points of confusion.

What is MADD?

In plain language, MADD is an inherited metabolic disorder that affects how your body creates energy ^[6].

To function, your body breaks down fats and proteins into fuel. This process happens inside the mitochondria (the “power plants” of your cells). In MADD, the body lacks enough of certain proteins—specifically electron transfer flavoprotein (ETF) or ETF-ubiquinone oxidoreductase (ETF-QO)—that act like electrical wires ^[7][8]. These “wires” are supposed to carry energy (electrons) from the breakdown of fats and proteins to the rest of the cell’s power system ^[7]. When they don’t work correctly, the body cannot access that energy, and metabolic byproducts can build up in the blood and urine ^[8][9].

Clearing Up the Name Confusion

You may hear your doctors use several different names for this condition. It is important to know that MADD and Glutaric acidemia type II (GA2) are the exact same condition ^[10]. The name GA2 exists because one of the substances that builds up in the urine is called glutaric acid ^[10].

When speaking to a new doctor or emergency room staff, you should state that you have “Multiple acyl-CoA dehydrogenase deficiency (MADD), also called glutaric acidemia type II (GA2).”

This name causes significant confusion because there is another, more common disorder called Glutaric acidemia type I (GA1).

While they share a similar name, GA1 and GA2 (MADD) are not the same:

• GA1 is caused by a defect in a single specific enzyme involved in breaking down only a few amino acids (lysine and tryptophan) ^[9].
• GA2 (MADD) is a “multiple” deficiency, meaning it affects the breakdown of many different fats and proteins simultaneously because the “electrical wire” (the ETF system) is impaired ^[7][8].
• The treatments, risks, and long-term outlook for these two conditions are very different ^[9][11]. Always ensure that any medical professional treating you understands the distinction.

A Wide Range of Experiences

MADD does not look the same for everyone. Historically, doctors grouped the condition into three broad clinical categories based on when symptoms start and how they appear:

1. Type I (Neonatal-onset with anomalies): Symptoms appear shortly after birth and may include physical differences in how the body developed before birth ^[12][13].
2. Type II (Neonatal-onset without anomalies): Symptoms appear shortly after birth but without physical developmental differences ^[12][14].
3. Type III (Late-onset): This form can appear at any time, from infancy through late adulthood. It is often milder than the neonatal forms and may first show up as muscle weakness, pain, or “crises” triggered by illness or fasting ^[12][15][2].

It is important to remember that these are historical clinical categories, not rigid boxes, and they do not perfectly match your genetics. The same genetic change can sometimes affect two people differently ^[16][17].

Moving Forward

A diagnosis is a tool, not a destiny. While MADD is a serious, lifelong condition, many people—especially those with late-onset forms—find that their symptoms improve significantly with specialized nutrition and, in many cases, under the supervision of a doctor, high doses of riboflavin (Vitamin B2) ^[18][14].

It is common to feel a sense of “genetic guilt” if you are a parent, but MADD is an autosomal recessive condition ^[8]. This means it occurs only when a person inherits two changed genes—one from each parent—who are typically healthy “carriers” themselves ^[4]. It is a random result of biology, not the result of anything you did or failed to do.

Your next steps will involve working with a metabolic specialist to create an individualized plan that keeps your body’s energy levels stable and prevents metabolic “crises” ^[6][13].